Form 4 · Filed Mar 3, 2026, 12:00 PM UTC
TRDA/Entrada Therapeutics, Inc.
Doshi Dipal — CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | F | other | 19,181 | $12 | $225,500 | 526,014 |
| Mar 2, 2026 | F | other | 9,869 | $12 | $115,052 | 545,195 |
| Mar 1, 2026 | A | other | 139,400 | $0 | — | 555,064 |
| Mar 1, 2026 | A | other | 208,000 | $0 | — | 208,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001613084-26-000001